Rosiglitazone For Type 2 Diabetes Does Not Increase Risk Of Cardiovascular Disease Or Death But Increases Heart Failure And Fractures In Women

June 9, 2009

Using rosiglitazone (Avandia) in combination with standard diabetes treatments (metformin or a sulfonylurea) to lower blood glucose in type 2 diabetics does not increase the risk of cardiovascular disease or death. However, the study confirms that using rosiglitazone more than doubles the risks of heart failure, and also increases the risk of fractures, mainly in women. The findings of the RECORD study are published in an Article Online First and in an upcoming edition of Read the rest of this entry »


Researchers Develop An Intelligent Chip Which Regulates Diabetes

June 7, 2009

Scientists of the Electronic Technology group of the University of Seville (US), led by Professor José Manuel Quero, have completed the first phase of Mireia, a research project financed by the Plan Nacional del Ministerio de Ciencia e Innovación (National Plan of the Spanish Science and Innovation Ministry), whose aim is to develop an intelligent chip to regulate diabetes in any kind of patients suffering this disease.

With this research, the idea is to extract the interstitial liquid with micro needles that are 200 microns long (the double than a hair’s thickness). This painless process is carried out with sensors and micro fluidics and patients are informed every now and again in their mobiles of their level of glucose.
Read the rest of this entry »


Researchers Develop An Intelligent Chip Which Regulates Diabetes

June 7, 2009

Scientists of the Electronic Technology group of the University of Seville (US), led by Professor José Manuel Quero, have completed the first phase of Mireia, a research project financed by the Plan Nacional del Ministerio de Ciencia e Innovación (National Plan of the Spanish Science and Innovation Ministry), whose aim is to develop an intelligent chip to regulate diabetes in any kind of patients suffering this disease.

With this research, the idea is to extract the interstitial liquid with micro needles that are 200 microns long (the double than a hair’s thickness). This painless process is carried out with sensors and micro fluidics and patients are informed every now and again in their mobiles of their level of glucose.
Read the rest of this entry »


Combination Therapy For Type 2 Diabetes With Rosiglitazone (RECORD Study) Shows No Increase Of Cardiovascular Disease Or Death

June 6, 2009

The results of the RECORD study are reported in an article published Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association (ADA) meeting in New Orleans, USA. They indicate that the use of rosiglitazone (Avandia) together with regular diabetes treatments (metformin or a sulfonylurea) to reduce blood glucose in type 2 diabetics does not raise the risk of cardiovascular disease or death. On the other hand, the research establishes that using rosiglitazone multiplies by more than two the risk of heart failure, and increases the risk of fracture, mostly in women.
Read the rest of this entry »


Combination Therapy For Type 2 Diabetes With Rosiglitazone (RECORD Study) Shows No Increase Of Cardiovascular Disease Or Death

June 6, 2009

The results of the RECORD study are reported in an article published Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association (ADA) meeting in New Orleans, USA. They indicate that the use of rosiglitazone (Avandia) together with regular diabetes treatments (metformin or a sulfonylurea) to reduce blood glucose in type 2 diabetics does not raise the risk of cardiovascular disease or death. On the other hand, the research establishes that using rosiglitazone multiplies by more than two the risk of heart failure, and increases the risk of fracture, mostly in women.
Read the rest of this entry »


Physician / Preventive Medicine Expert Explains How To Reverse Obesity And Diabetes Naturally

May 28, 2009

Irving A. Cohen, MD, MPH, will be at Book Expo America 2009, Booth 5065, May 29-31, to discuss his new book “Dr. Cohen’s Guide to the New Hippocratic Diet™: How to Really Lose Weight and Beat the Obesity Epidemic” It teaches dieters how to lose weight easily and naturally despite having failed before.

In his book, Dr. Cohen explains how three decades ago the Federal government tried to “fix” the problem of overweight adults by recommending low-fat diets for all Americans. They were wrong. As a result, four times as many Americans are overweight. Because most Americans believe that bad advice, they gain weight as they try to diet. The government blocks efforts to help those who are overweight or who may suffer from Type 2 Diabetes, unless they conform to that misguided government policy.
Read the rest of this entry »


Reducing Heart Attack Risk In Diabetes

May 25, 2009

People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published in The Lancet has shown.

By undertaking a meta-analysis which pooled information from five large trials, researchers at the University of Cambridge were for the first time able to provide reliable evidence linking intensive blood sugar level (or glucose) control with fewer heart attacks.
Read the rest of this entry »


Women With Gestational Diabetes During Pregnancy Have A Substantial And Persistently Elevated Risk Of Type 2 Diabetes Post-Birth

May 23, 2009

Women who develop gestational diabetes (GD) during pregnancy have a seven-and-a-half times increased risk of developing type 2 diabetes post-birth, which lasts throughout their lifetime. However, there is no agreed policy on the long-term follow up of these women and many do not return for the currently recommended 6-week post-birth diabetes check. An Article in this week’s diabetes special issue of The Lancet says that the strength of the association suggests that both disorders have an overlapping cause-and this should act as an incentive for women to attend the recommended post-birth check. This attendance could be an opportunity to provide advice on diet and exercise, and treatments to delay or prevent onset of diabetes-as well as alerting these women to symptoms of future diabetes, and to alert general practitioners responsible for their long-term care.
Read the rest of this entry »


Hypertension, Diabetes And Increased Carotid Artery Wall Thickness Means Increased Risk Of Stroke

April 25, 2009

Increased carotid artery wall thickness (CAWT), which can cause heart attack and stroke in many patients, is significantly related to diabetes and hypertension, according to a study performed at A.O.U. in Cagliari Sardegna, Italy (Chairman, Professor Giorgio Mallarini).

During the study, 186 patients were evaluated using multidetector row CT to see if CAWT is associated with cardiovascular risk factors such as hypertension, diabetes mellitus, dyslipidemia and a history of smoking. Results showed that there is a statistically significant relationship between diabetes and hypertension. “There was no significant statistical correlation between the increase of carotid wall thickness, smoking and dyslipidemia,” said Luca Saba, MD, lead author of the study.
Read the rest of this entry »


Benefit Of Vitamin D In Diabetes And Other Chronic Diseases

January 19, 2009

Vitamin D is quickly becoming the “it” nutrient with health benefits for diseases, including cancer, osteoporosis, heart disease and now diabetes.

A recent review article published by researchers from Loyola University Chicago Marcella Niehoff School of Nursing concluded that adequate intake of vitamin D may prevent or delay the onset of diabetes and reduce complications for those who have already been diagnosed. These findings appeared in the latest issue of Read the rest of this entry »